SE’s $2.2B Forte Biosciences, Inc. deal adds FB-102 to expand pipeline, but valuation & Vyvgart patent risks raise caution.
Rugonersen, a potentially best-in-class antisense oligonucleotide (ASO) therapy in development for Angelman syndrome, advanced into the pivotal ...
MedPage Today on MSN
First-in-Class Drug for ADHD Wins FDA Approval
Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older ...
5don MSN
Transcript: Vermont Sen. Bernie Sanders on "Face the Nation with Margaret Brennan," July 26, 2026
The following is the full transcription of an interview with Vermont Sen. Bernie Sanders, an Independent, a portion of which ...
However, that apparent improvement in educational outcomes is not reflected in state standardized test results. In 2025, just ...
This week I am behind the wheel of the 2026 Jeep Grand Wagoneer L Summit Obsidian 4X4, a full-sized, body-on-frame luxury SUV ...
MeiraGTx Holdings plc is positioned potentially for significant upside with late-stage gene therapy assets targeting large, ...
Mistfall Hunter launches July 29, 2026 on PC, PlayStation 5, and Xbox Series X|S, free on Xbox Game Pass. The dark fantasy ...
Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 studyWith the vast majority of PMD patients having no ...
I’m labeling and rating sidewalks from the comfort of my own couch in Los Angeles using Project Sidewalk, an online crowdsourcing platform dedicated to improving sidewalk accessibility. Part immersive ...
The US FDA has approved the first OTC tablet combining Tylenol (acetaminophen) and naproxen sodium, offering dual-action ...
A language takes work off your hands, gives it to a compiler, runtime, or toolchain, and charges you somewhere else.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results